CN102008360A - 一种用于修复脊髓损伤的人工神经网络样导管的构建 - Google Patents
一种用于修复脊髓损伤的人工神经网络样导管的构建 Download PDFInfo
- Publication number
- CN102008360A CN102008360A CN2010105061338A CN201010506133A CN102008360A CN 102008360 A CN102008360 A CN 102008360A CN 2010105061338 A CN2010105061338 A CN 2010105061338A CN 201010506133 A CN201010506133 A CN 201010506133A CN 102008360 A CN102008360 A CN 102008360A
- Authority
- CN
- China
- Prior art keywords
- neural network
- cell
- artificial neural
- mscs
- spinal cord
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000020431 spinal cord injury Diseases 0.000 title claims abstract description 22
- 238000013528 artificial neural network Methods 0.000 title claims abstract description 19
- 238000010276 construction Methods 0.000 title abstract description 4
- 230000008439 repair process Effects 0.000 claims abstract description 6
- 210000004027 cell Anatomy 0.000 claims description 44
- 210000004116 schwann cell Anatomy 0.000 claims description 23
- 239000000463 material Substances 0.000 claims description 20
- 238000012239 gene modification Methods 0.000 claims description 16
- 230000005017 genetic modification Effects 0.000 claims description 16
- 235000013617 genetically modified food Nutrition 0.000 claims description 16
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims description 14
- 208000028389 Nerve injury Diseases 0.000 claims description 5
- 230000008764 nerve damage Effects 0.000 claims description 5
- 239000010409 thin film Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 210000004504 adult stem cell Anatomy 0.000 claims description 3
- 229940117828 polylactic acid-polyglycolic acid copolymer Drugs 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 2
- 210000000130 stem cell Anatomy 0.000 claims description 2
- 210000002569 neuron Anatomy 0.000 abstract description 34
- 108010010803 Gelatin Proteins 0.000 abstract description 27
- 239000008273 gelatin Substances 0.000 abstract description 27
- 229920000159 gelatin Polymers 0.000 abstract description 27
- 235000019322 gelatine Nutrition 0.000 abstract description 27
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 27
- 238000000034 method Methods 0.000 abstract description 18
- 230000008929 regeneration Effects 0.000 abstract description 7
- 238000011069 regeneration method Methods 0.000 abstract description 7
- 210000000278 spinal cord Anatomy 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 4
- 230000018109 developmental process Effects 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 35
- 102100029268 Neurotrophin-3 Human genes 0.000 description 20
- 210000001178 neural stem cell Anatomy 0.000 description 17
- 230000004069 differentiation Effects 0.000 description 15
- 101150117329 NTRK3 gene Proteins 0.000 description 14
- 210000000225 synapse Anatomy 0.000 description 14
- 208000015181 infectious disease Diseases 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 10
- 102000004243 Tubulin Human genes 0.000 description 9
- 108090000704 Tubulin Proteins 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 102000047174 Disks Large Homolog 4 Human genes 0.000 description 8
- 108700019745 Disks Large Homolog 4 Proteins 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 101150069842 dlg4 gene Proteins 0.000 description 8
- 101150009249 MAP2 gene Proteins 0.000 description 7
- 238000000338 in vitro Methods 0.000 description 7
- 238000010186 staining Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 210000001185 bone marrow Anatomy 0.000 description 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 6
- 238000010166 immunofluorescence Methods 0.000 description 6
- 230000001242 postsynaptic effect Effects 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 239000013598 vector Substances 0.000 description 6
- 102000008730 Nestin Human genes 0.000 description 5
- 108010088225 Nestin Proteins 0.000 description 5
- 102000008763 Neurofilament Proteins Human genes 0.000 description 5
- 108010088373 Neurofilament Proteins Proteins 0.000 description 5
- 102100023206 Neuromodulin Human genes 0.000 description 5
- 101710144282 Neuromodulin Proteins 0.000 description 5
- 210000003169 central nervous system Anatomy 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000005090 green fluorescent protein Substances 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 210000005055 nestin Anatomy 0.000 description 5
- 210000005044 neurofilament Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 102000007469 Actins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108010025020 Nerve Growth Factor Proteins 0.000 description 4
- 102000004874 Synaptophysin Human genes 0.000 description 4
- 108090001076 Synaptophysin Proteins 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 4
- 239000012531 culture fluid Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000000946 synaptic effect Effects 0.000 description 4
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 3
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 210000003050 axon Anatomy 0.000 description 3
- 239000012620 biological material Substances 0.000 description 3
- 229940077737 brain-derived neurotrophic factor Drugs 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000002659 cell therapy Methods 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 239000010408 film Substances 0.000 description 3
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 210000003497 sciatic nerve Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 230000000472 traumatic effect Effects 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 244000050510 Cunninghamia lanceolata Species 0.000 description 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102000007665 Extracellular Signal-Regulated MAP Kinases Human genes 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 108010020004 Microtubule-Associated Proteins Proteins 0.000 description 2
- 102000009664 Microtubule-Associated Proteins Human genes 0.000 description 2
- 102000015336 Nerve Growth Factor Human genes 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000000515 collagen sponge Substances 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 238000012637 gene transfection Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 230000007830 nerve conduction Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 229920001432 poly(L-lactide) Polymers 0.000 description 2
- 230000003518 presynaptic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 210000001032 spinal nerve Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- JKYKXTRKURYNGW-UHFFFAOYSA-N 3,4-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C(O)=C(O)C(S(O)(=O)=O)=C2 JKYKXTRKURYNGW-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000010370 Adenoviridae Infections Diseases 0.000 description 1
- 206010060931 Adenovirus infection Diseases 0.000 description 1
- 241000380131 Ammophila arenaria Species 0.000 description 1
- 101001011741 Bos taurus Insulin Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 239000012824 ERK inhibitor Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 101710088172 HTH-type transcriptional regulator RipA Proteins 0.000 description 1
- 101000979001 Homo sapiens Methionine aminopeptidase 2 Proteins 0.000 description 1
- 101000969087 Homo sapiens Microtubule-associated protein 2 Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000109849 Leopardus jacobita Species 0.000 description 1
- 102100021118 Microtubule-associated protein 2 Human genes 0.000 description 1
- 102000007072 Nerve Growth Factors Human genes 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 206010033892 Paraplegia Diseases 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 206010037714 Quadriplegia Diseases 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000011589 adenoviridae infectious disease Diseases 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 210000001130 astrocyte Anatomy 0.000 description 1
- 230000010165 autogamy Effects 0.000 description 1
- 239000007640 basal medium Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- IXIBAKNTJSCKJM-BUBXBXGNSA-N bovine insulin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 IXIBAKNTJSCKJM-BUBXBXGNSA-N 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 210000002932 cholinergic neuron Anatomy 0.000 description 1
- 210000001612 chondrocyte Anatomy 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- DMBHHRLKUKUOEG-UHFFFAOYSA-N diphenylamine Chemical compound C=1C=CC=CC=1NC1=CC=CC=C1 DMBHHRLKUKUOEG-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000003037 histogenic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 238000010832 independent-sample T-test Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 210000002161 motor neuron Anatomy 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 210000004126 nerve fiber Anatomy 0.000 description 1
- 229940053128 nerve growth factor Drugs 0.000 description 1
- 208000028412 nervous system injury Diseases 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000014511 neuron projection development Effects 0.000 description 1
- 230000006576 neuronal survival Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 239000003900 neurotrophic factor Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000004248 oligodendroglia Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 210000001778 pluripotent stem cell Anatomy 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009822 protein phosphorylation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 210000002804 pyramidal tract Anatomy 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000010814 radioimmunoprecipitation assay Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000001044 sensory neuron Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010506133.8A CN102008360B (zh) | 2010-10-13 | 2010-10-13 | 一种用于修复脊髓损伤的人工神经网络样导管的构建 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010506133.8A CN102008360B (zh) | 2010-10-13 | 2010-10-13 | 一种用于修复脊髓损伤的人工神经网络样导管的构建 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102008360A true CN102008360A (zh) | 2011-04-13 |
CN102008360B CN102008360B (zh) | 2015-12-16 |
Family
ID=43838840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010506133.8A Active CN102008360B (zh) | 2010-10-13 | 2010-10-13 | 一种用于修复脊髓损伤的人工神经网络样导管的构建 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102008360B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104353113A (zh) * | 2014-08-29 | 2015-02-18 | 中山大学 | 一种用于修复脊髓损伤的类脊髓样组织的构建 |
CN104800885A (zh) * | 2015-05-13 | 2015-07-29 | 中山大学 | 一种具有趋化功能的生物活性支架的制备和应用 |
CN108452379A (zh) * | 2018-03-29 | 2018-08-28 | 天津市天津医院 | 用于修复椎间盘损伤的含有自体骨髓干细胞的明胶海绵材料及其使用方法 |
CN109938875A (zh) * | 2019-03-07 | 2019-06-28 | 宁波光远致信生物科技有限公司 | 一种神经假体及其制备方法和用途 |
CN110507859A (zh) * | 2018-05-22 | 2019-11-29 | 中山大学 | 含血管化区和轴突直行髓鞘化区的组织工程脊髓组织构建方法 |
CN110812532A (zh) * | 2019-08-20 | 2020-02-21 | 中山大学 | 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1339289A (zh) * | 2000-08-17 | 2002-03-13 | 中国科学院化学研究所 | 周围神经修复用组织工程诱导支架 |
CN1446907A (zh) * | 2003-04-18 | 2003-10-08 | 中山大学中山医学院科技开发中心 | 药物诱导神经干细胞增殖和分化的方法及应用 |
CN1449850A (zh) * | 2002-04-11 | 2003-10-22 | 财团法人工业技术研究院 | 多通道型生物吸收性神经再生导管及其制法 |
CN101318031A (zh) * | 2008-07-15 | 2008-12-10 | 中国人民解放军第二军医大学 | 神经元性组织工程化周围神经的制备方法 |
CN101653366A (zh) * | 2009-06-11 | 2010-02-24 | 广州中大中山医科技开发有限公司 | 一种用于修复神经损伤的明胶海绵圆柱体支架的构建 |
-
2010
- 2010-10-13 CN CN201010506133.8A patent/CN102008360B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1339289A (zh) * | 2000-08-17 | 2002-03-13 | 中国科学院化学研究所 | 周围神经修复用组织工程诱导支架 |
CN1449850A (zh) * | 2002-04-11 | 2003-10-22 | 财团法人工业技术研究院 | 多通道型生物吸收性神经再生导管及其制法 |
CN1446907A (zh) * | 2003-04-18 | 2003-10-08 | 中山大学中山医学院科技开发中心 | 药物诱导神经干细胞增殖和分化的方法及应用 |
CN101318031A (zh) * | 2008-07-15 | 2008-12-10 | 中国人民解放军第二军医大学 | 神经元性组织工程化周围神经的制备方法 |
CN101653366A (zh) * | 2009-06-11 | 2010-02-24 | 广州中大中山医科技开发有限公司 | 一种用于修复神经损伤的明胶海绵圆柱体支架的构建 |
Non-Patent Citations (5)
Title |
---|
YAN-QING ZHANG等: "NT-3 gene modified Schwann cells promote TrkC gene modified mesenchymal stem cells to differentiate into neuron-like cells in vitro", 《ANATOMICAL SCIENCE INTERNATIONAL》, vol. 85, no. 2, 13 June 2010 (2010-06-13), pages 61 - 67 * |
YI XIONG等: "Synaptic transmission of neural stem cells seeded in 3-dimensional PLGA scaffolds", 《BIOMATERIALS》, vol. 30, no. 22, 17 August 2009 (2009-08-17), pages 3711 - 3722, XP026133667, DOI: 10.1016/j.biomaterials.2009.03.046 * |
刘爽等: "脊髓损伤的细胞移植治疗", 《中华器官移植杂志》, vol. 27, no. 7, 31 December 2006 (2006-12-31), pages 443 - 445 * |
张燕青等: "神经营养素-3基因修饰雪旺细胞和神经营养素-受体基因修饰脊髓间充质干细胞联合移植促进脊髓损伤大鼠神经元存活的研究", 《中国康复医学杂志》, vol. 24, no. 7, 31 December 2009 (2009-12-31) * |
杨慧民等: "骨髓间充质干细胞诱导分化为神经样细胞的离子通道:是否有电生理特性?", 《中国组织工程研究与临床康复》, vol. 13, no. 40, 1 October 2009 (2009-10-01), pages 7881 - 7884 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104353113A (zh) * | 2014-08-29 | 2015-02-18 | 中山大学 | 一种用于修复脊髓损伤的类脊髓样组织的构建 |
CN104800885A (zh) * | 2015-05-13 | 2015-07-29 | 中山大学 | 一种具有趋化功能的生物活性支架的制备和应用 |
CN108452379A (zh) * | 2018-03-29 | 2018-08-28 | 天津市天津医院 | 用于修复椎间盘损伤的含有自体骨髓干细胞的明胶海绵材料及其使用方法 |
CN110507859A (zh) * | 2018-05-22 | 2019-11-29 | 中山大学 | 含血管化区和轴突直行髓鞘化区的组织工程脊髓组织构建方法 |
CN109938875A (zh) * | 2019-03-07 | 2019-06-28 | 宁波光远致信生物科技有限公司 | 一种神经假体及其制备方法和用途 |
CN110812532A (zh) * | 2019-08-20 | 2020-02-21 | 中山大学 | 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102008360B (zh) | 2015-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Keire et al. | Isolation and culture of skeletal muscle myofibers as a means to analyze satellite cells | |
Danoviz et al. | Skeletal muscle satellite cells: background and methods for isolation and analysis in a primary culture system | |
US20050014255A1 (en) | Stem cells for clinical and commercial uses | |
JP6687757B2 (ja) | 3d軟骨オルガノイドブロックを調製するための方法 | |
CN102008360B (zh) | 一种用于修复脊髓损伤的人工神经网络样导管的构建 | |
Schlüter et al. | Adult ventricular cardiomyocytes: isolation and culture | |
WO2009133943A1 (ja) | 生体内機能的細胞の高効率採取法 | |
CN101802174A (zh) | 细胞增殖方法以及用于组织修复及再生的药物 | |
CN101801396A (zh) | 治疗神经变性的方法和组合物 | |
CN103930542A (zh) | 棕色脂肪细胞组合物及方法 | |
Stuelsatz et al. | Isolation, culture, and immunostaining of skeletal muscle myofibers from wildtype and nestin-GFP mice as a means to analyze satellite cells | |
Su et al. | Isolation, culture, and characterization of primary salivary gland cells | |
CN111575227B (zh) | 一种人源性糖尿病心肌病疾病模型的建立方法 | |
Galli et al. | Adult neural stem cells | |
Peng et al. | Effects of transplantation of FGF-2-transfected MSCs and XACB on TNF-α expression with avascular necrosis of the femoral head in rabbits | |
Fraccarollo et al. | Modeling cardiac fibrosis in mice:(myo) fibroblast phenotype after ischemia | |
JP2010181391A (ja) | 動物細胞の識別方法 | |
US20210180018A1 (en) | Composition for promoting stem cell differentiation, comprising progenitor cell culture solution and multilayer graphene film, and use thereof | |
Izumi et al. | Enrichment of oral mucosa and skin keratinocyte progenitor/stem cells | |
CN106434540A (zh) | 一种细胞培养液及其应用和诱导骨骼肌干细胞向骨细胞分化的方法 | |
Wu et al. | Purification of Schwann cells from adult rats by differential detachment | |
Morton et al. | Isolation of Extracellular Vesicles from Subventricular Zone Neural Stem Cells | |
Eder et al. | Introducing the concept of the 3Rs into tissue engineering research | |
Cromeens et al. | Critical intestinal cells originate from the host in enteroid-derived tissue-engineered intestine | |
CN110812532A (zh) | 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181008 Address after: 510080 74 Zhongshan road two Yuexiu District Zhongshan Guangzhou Guangdong Patentee after: SUN YAT-SEN University Address before: 510080 74 Zhongshan two road, Guangzhou, Guangdong Co-patentee before: Guangzhou Zhongda Zhongshan Medical Technology Development Co.,Ltd. Patentee before: Sun Yat-sen University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231218 Address after: 518000, Block 1804, Unit 1, Unit B, Coolpad Building, Songpingshan Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province, China Patentee after: Shenzhen Baiaosaikang Biotechnology Co.,Ltd. Address before: 510080, No. two, No. 74, Zhongshan Road, Guangzhou, Guangdong, Yuexiu District Patentee before: SUN YAT-SEN University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240410 Address after: 518000 Room 201, building A, No. 1, Qian Wan Road, Qianhai Shenzhen Hong Kong cooperation zone, Shenzhen, Guangdong (Shenzhen Qianhai business secretary Co., Ltd.) Patentee after: Century Evergreen Biotechnology (Shenzhen) Co.,Ltd. Country or region after: China Address before: 518000, Block 1804, Unit 1, Unit B, Coolpad Building, Songpingshan Community, Xili Street, Nanshan District, Shenzhen City, Guangdong Province, China Patentee before: Shenzhen Baiaosaikang Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240522 Address after: Room 2001, No. 126 South Huadi Avenue, Liwan District, Guangzhou City, Guangdong Province, 510000 Patentee after: Zeng Xiang Country or region after: China Address before: 518000 Room 201, building A, No. 1, Qian Wan Road, Qianhai Shenzhen Hong Kong cooperation zone, Shenzhen, Guangdong (Shenzhen Qianhai business secretary Co., Ltd.) Patentee before: Century Evergreen Biotechnology (Shenzhen) Co.,Ltd. Country or region before: China |